WELLER, K.; STAUBACH, P.; METZ, M.; CHAPMAN-ROTHE, N.; SIEDER, C.; BRAUTIGAM, M.; MAURER, M. Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S53, 2018. DOI: 10.25251/skin.2.supp.53. Disponível em: https://jofskin.org/index.php/skin/article/view/299. Acesso em: 22 jul. 2024.